Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Submitting Marketing Applications According to the ICH/CTD Format: General Considerations

Submitting Marketing Applications According to the ICH/CTD Format: General Considerations

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

September 1, 2001

April 5, 2019

Center for Drug Evaluation and Research

aab838ec-4495-4d46-a53a-ccd911049363

Related Documents

Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action

Guidance DocumentApril 3, 2003Center for Drug Evaluation and Research
View Details →

Submitting Debarment Certification Statements

Guidance DocumentOctober 2, 1998Center for Drug Evaluation and Research
View Details →

How to Comply with the Pediatric Research Equity Act

Guidance DocumentSeptember 7, 2005Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.